BOYS, MARK LAURENCE,BRADLEY, MICHAEL,DELISLE, ROBERT KIRK,HENNINGS, D. DAVID,KENNEDY, APRIL L.,MEDINA, MATTHEW,MUNSON, MARK C.,RAST, BRYSON,RIZZI, JAMES P.,RODRIGUEZ, MARTHA E.,TOPALOV, GEORGE T.,ZHAO
申请号：
TW99145074
公开号：
TWI471326B
申请日:
2010.12.21
申请国别(地区):
TW
年份:
2015
代理人:
摘要：
Compounds of Formula (I): and pharmaceutically acceptable salts thereof in which R1, R2, R3, R4 and R5 have the meanings given in the specification, are inhibitors of cFMS and are useful in the treatment of bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases and pain.
